Global Sexually Transmitted Diseases Testing Market Report and Forecast 2023-2028

Global Sexually Transmitted Diseases Testing Market Report and Forecast 2023-2028


Market Outlook

According to the report by Expert Market Research (EMR), the global sexually transmitted diseases testing market reached a value of around USD 96.9 billion in 2022. Aided by the increasing prevalence of sexually transmitted diseases worldwide and the growing awareness about the importance of early diagnosis and treatment, the market is projected to further grow at a CAGR of 5.80% between 2023 and 2028 to reach a value of USD 128.45 billion by 2028.

Sexually transmitted diseases, such as HIV/AIDS, syphilis, gonorrhoea, and chlamydia, among others, represent a significant public health challenge worldwide. Early detection and treatment are crucial to preventing severe health complications and controlling the spread of these diseases. STD testing is, therefore, an essential part of preventive healthcare and is used in various settings, from public health clinics and hospitals to private practices and home-based testing.

The increasing prevalence of STDs is the primary driver of the global sexually transmitted diseases testing market growth. According to the World Health Organisation, over 1 million sexually transmitted infections are acquired every day worldwide. These alarming statistics underline the urgent need for accessible and accurate STD testing services.

In parallel, there is growing awareness of the importance of early diagnosis and treatment of STDs. This increased awareness is largely due to extensive public health campaigns and education initiatives that highlight the importance of regular testing, particularly for high-risk populations.

Furthermore, the sexually transmitted diseases testing market is witnessing the rapid development and commercialisation of innovative diagnostic technologies, such as rapid point-of-care tests and advanced molecular diagnostic platforms. These innovations enable more accurate, faster, and more convenient testing, which is key to increasing testing rates and controlling the spread of STDs.

In addition to these factors, the global push towards universal health coverage, including sexual and reproductive health services, is expected to significantly increase access to STD testing services, thus contributing to the sexually transmitted diseases testing market expansion.

The ongoing advancements in diagnostic technologies, coupled with increasing public health efforts to increase access to testing and reduce stigma, are expected to continue driving the sexually transmitted diseases testing market growth over the forecast period.

Market Segmentation

The market can be divided based on disease type, device type, and region.

Market Breakup by Disease Type
  • Chlamydia
  • Gonorrhoea
  • Herpes Simplex Virus
  • Syphilis
  • Human Papillomavirus (HPV)
  • Others
Market Breakup by Device Type
  • Laboratory Devices
  • Thermal Cyclers- PCR
  • Lateral Flow Readers
  • Flow Cytometers
  • Differential Light Scattering Machines
  • Absorbance Microplate Reader
  • Others
  • Point of Care (POC) Devices
  • Phone Chips (Microfluidics and ICT)
  • Portable/Bench Top/Rapid Diagnostic
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Competitive Landscape

The EMR report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the global sexually transmitted diseases testing companies. Some of the major key players explored in the report by Expert Market Research are as follows:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • bioMérieux SA
  • Thermo Fisher Scientific Inc.
  • Quidel Corporation
  • Hologic, Inc.
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A
  • QIAGEN GmbH
  • Becton, Dickinson and Company
  • Others
About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.

*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Sexually Transmitted Diseases Testing Market Analysis
8.1 Key Industry Highlights
8.2 Global Sexually Transmitted Diseases Testing Historical Market (2018-2022)
8.3 Global Sexually Transmitted Diseases Testing Market Forecast (2023-2028)
8.4 Global Sexually Transmitted Diseases Testing Market by Disease Type
8.4.1 Chlamydia
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Gonorrhoea
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Herpes Simplex Virus
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Syphilis
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2022)
8.4.4.3 Forecast Trend (2023-2028)
8.4.5 Human Papillomavirus (HPV)
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2018-2022)
8.4.5.3 Forecast Trend (2023-2028)
8.4.6 Others
8.5 Global Sexually Transmitted Diseases Testing Market by Device Type
8.5.1 Laboratory Devices
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.1.4 Breakup by Type
8.5.1.4.1 Thermal Cyclers- PCR
8.5.1.4.2 Lateral Flow Readers
8.5.1.4.3 Flow Cytometers
8.5.1.4.4 Differential Light Scattering Machines
8.5.1.4.5 Absorbance Microplate Reader
8.5.1.4.6 Others
8.5.2 Point of Care (POC) Devices
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.2.4 Breakup by Type
8.5.2.4.1 Phone Chips (Microfluidics and ICT)
8.5.2.4.2 Portable/Bench Top/Rapid Diagnostic
8.6 Global Sexually Transmitted Diseases Testing Market by Region
8.6.1 North America
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Europe
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Asia Pacific
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Latin America
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.6.5 Middle East and Africa
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2018-2022)
8.6.5.3 Forecast Trend (2023-2028)
9 North America Sexually Transmitted Diseases Testing Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Sexually Transmitted Diseases Testing Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Sexually Transmitted Diseases Testing Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Sexually Transmitted Diseases Testing Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Sexually Transmitted Diseases Testing Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 F. Hoffmann-La Roche Ltd
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Abbott Laboratories
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 bioMérieux SA
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Thermo Fisher Scientific Inc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Quidel Corporation
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Hologic, Inc.
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Bio-Rad Laboratories, Inc.
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 DiaSorin S.p.A
15.2.8.1 Company Overview
15.2.8.2 Product Portfolio
15.2.8.3 Demographic Reach and Achievements
15.2.8.4 Certifications
15.2.9 QIAGEN GmbH
15.2.9.1 Company Overview
15.2.9.2 Product Portfolio
15.2.9.3 Demographic Reach and Achievements
15.2.9.4 Certifications
15.2.10 Becton, Dickinson and Company
15.2.10.1 Company Overview
15.2.10.2 Product Portfolio
15.2.10.3 Demographic Reach and Achievements
15.2.10.4 Certifications
15.2.11 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Sexually Transmitted Diseases Testing Market: Key Industry Highlights, 2018 and 2032
2. Global Sexually Transmitted Diseases Testing Historical Market: Breakup by Disease Type (USD Million), 2018-2022
3. Global Sexually Transmitted Diseases Testing Market Forecast: Breakup by Disease Type (USD Million), 2023-2028
4. Global Sexually Transmitted Diseases Testing Historical Market: Breakup by Device Type (USD Million), 2018-2022
5. Global Sexually Transmitted Diseases Testing Market Forecast: Breakup by Device Type (USD Million), 2023-2028
6. Global Sexually Transmitted Diseases Testing Historical Market: Breakup by Region (USD Million), 2018-2022
7. Global Sexually Transmitted Diseases Testing Market Forecast: Breakup by Region (USD Million), 2023-2028
8. North America Sexually Transmitted Diseases Testing Historical Market: Breakup by Country (USD Million), 2018-2022
9. North America Sexually Transmitted Diseases Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
10. Europe Sexually Transmitted Diseases Testing Historical Market: Breakup by Country (USD Million), 2018-2022
11. Europe Sexually Transmitted Diseases Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Asia Pacific Sexually Transmitted Diseases Testing Historical Market: Breakup by Country (USD Million), 2018-2022
13. Asia Pacific Sexually Transmitted Diseases Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Latin America Sexually Transmitted Diseases Testing Historical Market: Breakup by Country (USD Million), 2018-2022
15. Latin America Sexually Transmitted Diseases Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Middle East and Africa Sexually Transmitted Diseases Testing Historical Market: Breakup by Country (USD Million), 2018-2022
17. Middle East and Africa Sexually Transmitted Diseases Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Global Sexually Transmitted Diseases Testing Market Structure

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings